CDC20 with malignant progression and poor prognosis of astrocytoma revealed by analysis on gene expression

Multidimensional analysis of gene expression reveals TGFB1I1-induced EMT contributes to malignant progression of astrocytomas

(2015) Yanwei Liu et al.   Oncotarget

Cdc20 and securin overexpression predict short-term breast cancer survival

(2014) H Karra et al.   BRITISH JOURNAL OF CANCER

Inhibition of polo-like kinase 1 in glioblastoma multiforme induces mitotic catastrophe and enhances radiosensitisation

(2013) Anita T. Tandle et al.   EUROPEAN JOURNAL OF CANCER

CDC20 overexpression predicts a poor prognosis for patients with colorectal cancer

(2013) Wen-jing Wu et al.   Journal of Translational Medicine

Increased CDC20 expression is associated with pancreatic ductal adenocarcinoma differentiation and progression

(2012) David Z Chang et al.   Journal of Hematology & Oncology

Overexpression of CDC20 predicts poor prognosis in primary non-small cell lung cancer patients

(2012) Tatsuya Kato et al.   JOURNAL OF SURGICAL ONCOLOGY

The Accuracy of Survival Time Prediction for Patients with Glioma Is Improved by Measuring Mitotic Spindle Checkpoint Gene Expression

(2011) Li Bie et al.   PLoS One

MGMT promoter hypermethylation is a frequent, early, and consistent event in astrocytoma progression, and not correlated with TP53 mutation

(2010) Floris H. Groenendijk et al.   JOURNAL OF NEURO-ONCOLOGY

Multifaceted polo-like kinases: drug targets and antitargets for cancer therapy

(2010) Klaus Strebhardt   NATURE REVIEWS DRUG DISCOVERY

Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources

(2009) Da Wei Huang et al.   Nature Protocols

Under arrest in mitosis: Cdc20 dies twice

(2008) Andrew M. Fry et al.   NATURE CELL BIOLOGY

Gene expression profiling in glioblastoma and immunohistochemical evaluation of IGFBP-2 and CDC20

(2008) Gianluca Marucci et al.   VIRCHOWS ARCHIV